1364890-22-1 Usage
Description
(R)-3-(pyrrolidin-2-yl)benzonitrile hydrochloride is a chemical compound utilized in pharmaceutical research and development. It is a crystalline solid, typically stored and handled as a hydrochloride salt, and is known for its potential applications in the development of new medications. (R)-3-(pyrrolidin-2-yl)benzonitrile hydrochloride is also of interest in the field of organic chemistry due to its reactivity and potential use in various synthetic processes.
Uses
Used in Pharmaceutical Research and Development:
(R)-3-(pyrrolidin-2-yl)benzonitrile hydrochloride is used as a starting material for the synthesis of various drugs and pharmaceuticals. Its role in this application is crucial for the development of new medications, as it can be transformed into a wide range of therapeutic compounds.
Used in Production of Pharmaceutical Intermediates:
In the pharmaceutical industry, (R)-3-(pyrrolidin-2-yl)benzonitrile hydrochloride is used as a key component in the production of pharmaceutical intermediates. These intermediates are essential building blocks in the synthesis of final drug products, making this compound a valuable asset in the development pipeline.
Used in Organic Chemistry Research:
(R)-3-(pyrrolidin-2-yl)benzonitrile hydrochloride is also used in the field of organic chemistry as a subject of study for its reactivity and potential use in various synthetic processes. Researchers explore its properties and interactions with other compounds to discover new methods and applications in chemical synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 1364890-22-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,4,8,9 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1364890-22:
(9*1)+(8*3)+(7*6)+(6*4)+(5*8)+(4*9)+(3*0)+(2*2)+(1*2)=181
181 % 10 = 1
So 1364890-22-1 is a valid CAS Registry Number.
1364890-22-1Relevant articles and documents
COMPOUNDS AND COMPOSITIONS AS TRK INHIBITORS
-
Page/Page column 81, (2012/03/27)
The invention provides compounds of formula (I), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TRK kinase activity. wherein: and the rest of the variables are as specified in the claims.
